Holen Sie sich die Stockscreener-App
2.23
4.21%
0.09
Schlusskurs vom Vortag:
$2.14
Offen:
$2.04
24-Stunden-Volumen:
70,229
Relative Volume:
0.59
Marktkapitalisierung:
$157.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.97M
KGV:
-2.2571
EPS:
-0.988
Netto-Cashflow:
$-1.18M
1W Leistung:
+17.37%
1M Leistung:
-28.18%
6M Leistung:
-81.93%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.02
$2.2499
1-Wochen-Bereich:
$1.90
$3.05
52-Wochen-Spanne:
$1.70
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
2.23 | 157.95M | 0 | -2.97M | -1.18M | -0.988 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Yd Bio Ltd Aktie (YDES) Neueste Nachrichten
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Which stocks have an unusual volume on Tuesday? - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
YD Bio affiliate obtains lab licenses in Rhode Island, Pennsylvania - Investing.com
YD Bio affiliate obtains lab licenses in Rhode Island, Pennsylvania By Investing.com - Investing.com Canada
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - Yahoo Finance
YD Bio expands cancer-testing lab access to 46 states - Stock Titan
RSU grant and exercise update for YD Bio (YDES) director Lu - Stock Titan
RSU grant and exercise for YD Bio (YDES) director Chang Kochi - Stock Titan
YD Bio Ltd (NASDAQ: YDES) Share Price, YDES Stock News, YDES Share Price & Updates - Kalkine
MegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California Facility - Yahoo Finance
Morning Market Movers: CUPR, BNC, ABSI, WEN See Big Swings - RTTNews
YD Bio Ord Shs (YDES) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BRZHR Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
YD Bio Ord Shs (YDES) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
YD Bio Ord Shs (YDES) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
YD Bio Ord Shs (YDES) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
YD Bio Ord Shs (YDES) Institutional Confidence - TradingKey
YD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
YD Bio Ord Shs (YDES) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
YD Bio Ord Shs (YDES) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
YD Bio Ord Shs (YDES) Valuation: PE, PB & Fair Value Analysis - TradingKey
Morning Market Movers: SLBT, SCLX, TDIC, CRE See Big Swings - RTTNews
FOCL Stock Price and Chart — NASDAQ:FOCL - TradingView
[EFFECT] YD Bio Ltd SEC Filing - Stock Titan
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview - Yahoo Finance
YD Bio Stock Is Falling Again: The SEC Filing Behind the Slide - Bez Kabli
iGan Partners Invests in Adenocyte Ltd to Advance the Early Detection of Pancreatic Cancer - Yahoo Finance
YDESYD Bio Ltd Stock Price and Quote - Finviz
YD Bio (NASDAQ: YDES) prospectus lists 58.6M resale shares, 11.4M exercisable - Stock Titan
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX) - Yahoo Finance
Registrar Corp and U.S. Commercial Service Strengthen Partnership to Support Australian Companies Expanding into the U.S. - Yahoo Finance
Yourgene Health Launches Insight DPYD Assay - Yahoo Finance
Affiliated (MGRE) Steady at $$24.02 — Awaiting Next Catalyst 2026-05-13Rip Sell Trade - The Legal Advocate
YD Bio Limited Ordinary Shares Stock Forecast Summary - Meyka
Autoliv posts upbeat Q1 results, joins United Airlines, Royal Caribbean Cruises and other big stocks moving higher on Friday - MSN
YD Bio Limited Reports Full Year 2025 Financial Results - ChartMill
YD Bio Limited Reports Financial Results for Full Year 2025, Achieves 17% Revenue Growth and Strategic Advances in Healthcare Innovations - Quiver Quantitative
YD Bio 2025 Loss/Shr 12c >YDES - Moomoo
After a $13.9M equity raise, YD Bio enters 2026 with $6M cash - Stock Titan
Going concern warning tops YD Bio (NASDAQ: YDES) 20-F risk disclosures - Stock Titan
Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update - Yahoo Finance
Unusual VolumeStock ScreenerNews - Finviz
Immuneering Corp (IMRX) Stock Price, Quote, News & History - Benzinga
CMMB (Chemomab Therapeutics Ltd. American Depositary Share) posts narrower Q4 2025 loss than estimates, while shares dip modestly.Community Trade Ideas - Xã Thanh Hà
What is happening with Elbit Systems (ESLT) stock today (Smart Money Active) 2026-04-20High Interest Stocks - Cổng thông tin điện tử tỉnh Lào Cai
[Form 3/A] YD Bio Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan
Shao Ta Lu Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday - Sahm
Man Edmund Hen Net Worth (2026) - GuruFocus
Finanzdaten der Yd Bio Ltd-Aktie (YDES)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):